Global Central Nervous System Disorders Therapeutics Market to Surpass US$ 202.7 Million by 2028, Says Coherent Market Insights (CMI) SEATTLE, Aug. 05, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global central nervous system disorders therapeutics market is estimated to be valued at US$ 131.3 million in...

Lexaria DehydraTECH Shows Promise in Nervous System Disorders -- CFN Media SEATTLE, WA, July 05, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced...